PCRX

Pacira Pharmaceuticals’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Dave Stack Thanks, Jessica. Good morning everyone and thank you for joining us today. The primary focus of our call today is EXPAREL, our novel multimodal treatment for post-surgical pain that surgically … moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click […]

7:20 am Pacira Pharma beats by $0.04, beats on revs

moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]

Pacira Pharmaceuticals, Inc. Reports 2013 Financial Results: Fourth Quarter EXPAREL Revenues Increase 53 Percent Over Third Quarter

[Business Wire] – Pacira Pharmaceuticals, Inc. today provided updates on the commercial success of EXPAREL® for postsurgical pain in the Un moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]

Pacira Pharmaceuticals, Inc. Announces Timing for 2013 Financial Results Webcast and Conference Call

[Business Wire] – Pacira Pharmaceuticals, Inc. today announced that financial results for the company’s fourth quarter and year ended December 31, 2013, will be released before the market opens on Tuesday, February 25, 2014. moreView todays social media effects on PCRXView the latest stocks trending across Twitter. Click to view dashboardSee who Pacira is hiring next, click here to view […]